解读UBE4B酸化动态:p53积累和癌细胞对DNA损伤反应的关键机制
Yasser Abuetabh1, H Helena Wu1, Habib Al Yousef1
1370 Heritage Medical Research Center, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, T6G 2S2, Canada.
Cell death discovery
|April 2, 2025
概括
UBE4B蛋白调节了瘤抑制剂p53. DNA 损伤触发了 UBE4B 酸化,减少了 p53 的结合并激活了 p53. Wip1脱酸化稳定了UBE4B,影响了癌细胞的生长.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞信号传输 细胞信号传输
背景情况:
- 瘤抑制剂p53对于通过细胞循环停止,DNA修复,衰老和亡来消除致癌威胁至关重要.
- 在正常条件下和DNA损伤后,UBE4B负调节p53,向酸化p53进行降解.
- 在癌症中对DNA损伤的反应中,UBE4B的调节仍然不太清楚.
研究的目的:
- 研究调节UBE4B在癌症中对DNA损伤的反应中的酸化和脱酸化机制.
- 阐明Wip1在UBE4B脱化中的作用及其对p53稳定性的影响.
- 探索针对癌症治疗中的UBE4B调节的治疗潜力.
主要方法:
- 在对DNA损伤的反应中研究了UBE4B酸化和脱酸化.
- 在不同的酸化状态下评估了UBE4B和p53之间的结合亲和力.
- 利用Wip1抑制来研究其对UBE4B活性和p53积累的影响.
- 在UBE4B酸化中检查了ATR介导的信号.
主要成果:
- 由ATR信号介导的UBE4B酸化降低了它与p53的结合亲和力,导致p53的积累.
- Wip1去酸化UBE4B,稳定其在对DNA损伤的反应中的活性.
- 抑制Wip1显著增加了UBE4B的酸化,导致p53积累更多,细胞生长减少.
- 通过酸化/脱酸化调节UBE4B对p53稳定性和癌细胞增殖至关重要.
结论:
- UBE4B化/脱化是对p53稳定性的关键调节机制,用于应对DNA损伤.
- Wip1在去化UBE4B中起着至关重要的作用,影响p53水平和癌细胞生长.
- 准癌细胞中的UBE4B调节可能为改善患者治疗结果提供新的治疗策略.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K


